Anonymous
Guest
Anonymous
Guest
Sales we have are because of reps activity. Without our constant promotion over four years there would be only very isolated pockets of business. Reps have made a difference.
Sales are not what they could have been,considering the quality of the product, but a few billion over the product life is not nothing either.
Eliminate FDO and market share would triple within a year.
ROI per rep still high. Many companies don't even approach it with their best products.
Stop comparing to companies and products that (perhaps deservedly) outperform NPC and Gilenya, just realize that some significant benefit for patients can come from the product, and some substantial revenue for the company...but it will take reps to make it happen.
There may be ways to reduce costs within MSBU, but fewer reps would also reduce revenues.
Do I really need to point out that this is NOT a product that sells itself?
Sales are not what they could have been,considering the quality of the product, but a few billion over the product life is not nothing either.
Eliminate FDO and market share would triple within a year.
ROI per rep still high. Many companies don't even approach it with their best products.
Stop comparing to companies and products that (perhaps deservedly) outperform NPC and Gilenya, just realize that some significant benefit for patients can come from the product, and some substantial revenue for the company...but it will take reps to make it happen.
There may be ways to reduce costs within MSBU, but fewer reps would also reduce revenues.
Do I really need to point out that this is NOT a product that sells itself?